Human Embryonic Stem Cell Market is to Hit $10.7 billion by 2015 Says Latest Report
Piribo, the online destination for Pharma intelligence, has added a new report.
By: Joe Walsh
Embryonic stem cell (hESC) research has attracted a lot of attention the world over and the controversy surrounding it just does not seem to die down. Stem cells are unspecialised cells that are capable of differentiating into any other cell type. In addition to being crucial for humans, stem cells also form an important tool in research for finding cures for a host of diseases. Adult, umbilical cord blood and embryos constitute the three sources of stem cells, of which embryonic stem cells have been the subject of major research activities.
Embryonic Stem Cell Technologies analysed in this study include Stem Cell Transplants, Cell Based Genomics, Xenotransplants and Other. The report also analyzes the market for hESC therapeutic areas including Central Nervous System (CNS), Tissue Engineering, Oncology, Cardiology and Other Disease Areas.The worldwide market for hESCs is estimated at US$3.8 billion in 2010. Growing at a robust CAGR of 24.8% during the period 2007-2015, the market is projected to reach US$10.7 billion by 2015.
The report “Human Embryonic Stem Cells: A Global Market Overview” is available from Piribo at:
Piribo product ID: INX00010